5208 results
-
List item
Committee for Orphan Medicinal Products (COMP): 10-12 May 2021 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 10/05/2021 to 12/05/2021, Last updated: 10/05/2021 -
List item
Committee for Orphan Medicinal Products (COMP): 13-15 April 2021 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 13/04/2021 to 15/04/2021, Last updated: 13/04/2021 -
List item
Press briefing on the conclusion of the investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events by the Pharmacovigilance Risk Assessment Committee (PRAC)
Virtual meeting, 18/03/2021, Last updated: 19/03/2021 -
List item
News: COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets
PRAC, Last updated: 19/03/2021 -
List item
Committee for Orphan Medicinal Products (COMP): 16-18 February 2021
European Medicines Agency, Amsterdam, the Netherlands, from 16/02/2021 to 18/02/2021, Last updated: 01/03/2021 -
List item
Workshop on support for orphan medicines development
Virtual event, 30/11/2020, Last updated: 25/02/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 February 2021
European Medicines Agency, Amsterdam, the Netherlands, from 08/02/2021 to 11/02/2021, Last updated: 08/02/2021 -
List item
Committee for Orphan Medicinal Products (COMP): 19-21 January 2021
European Medicines Agency, Amsterdam, the Netherlands, from 19/01/2021 to 21/01/2021, Last updated: 03/02/2021 -
List item
Committee for Orphan Medicinal Products (COMP): 3-5 November 2020
Virtual meeting, from 03/11/2020 to 05/11/2020, Last updated: 03/02/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 26-29 October 2020
Virtual meeting, from 26/10/2020 to 29/10/2020, Last updated: 08/01/2021 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 July 2020
European Medicines Agency, Amsterdam, the Netherlands, from 06/07/2020 to 09/07/2020, Last updated: 10/12/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 23-26 November 2020
Virtual meeting, from 23/11/2020 to 26/11/2020, Last updated: 27/11/2020 -
List item
News: Call for independent scientific experts to join EMA's Pharmacovigilance Risk Assessment Committee (PRAC) - deadline extended
PRAC, Last updated: 20/11/2020 -
List item
Committee for Orphan Medicinal Products (COMP): 8-10 September 2020
Virtual meeting, from 08/09/2020 to 10/09/2020, Last updated: 12/11/2020 -
List item
Committee for Orphan Medicinal Products (COMP): 14-16 July 2020
European Medicines Agency, Amsterdam, the Netherlands, from 14/07/2020 to 16/07/2020, Last updated: 14/10/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 14-17 April 2020
European Medicines Agency, Amsterdam, the Netherlands, from 14/04/2020 to 17/04/2020, Last updated: 14/10/2020 -
List item
Committee for Orphan Medicinal Products (COMP): 6-8 October 2020
Virtual meeting, from 06/10/2020 to 08/10/2020, Last updated: 08/10/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 28 September-1 October 2020
Virtual meeting, from 28/09/2020 to 01/10/2020, Last updated: 29/09/2020 -
List item
Committee for Orphan Medicinal Products (COMP): 16-18 June 2020
European Medicines Agency, Amsterdam, the Netherlands, from 16/06/2020 to 18/06/2020, Last updated: 07/08/2020 -
List item
Committee for Orphan Medicinal Products (COMP): 18-20 May 2020
European Medicines Agency, Amsterdam, the Netherlands, from 18/05/2020 to 20/05/2020, Last updated: 25/06/2020 -
List item
Committee for Orphan Medicinal Products (COMP): 17-19 March 2020
European Medicines Agency, Amsterdam, the Netherlands, from 17/03/2020 to 19/03/2020, Last updated: 15/05/2020 -
List item
Committee for Orphan Medicinal Products (COMP): 18-20 February 2020
European Medicines Agency, Amsterdam, the Netherlands, from 18/02/2020 to 20/02/2020, Last updated: 09/03/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 9-12 March 2020
from 09/03/2020 to 12/03/2020, Last updated: 06/03/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 30 September-3 October 2019
European Medicines Agency, Amsterdam, the Netherlands, from 30/09/2019 to 03/10/2019, Last updated: 19/02/2020 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 13-16 January 2020
European Medicines Agency, Spark building, Orlyplein 24, Amsterdam 1043 DP, The Netherlands, from 13/01/2020 to 16/01/2020, Last updated: 13/01/2020